222 related articles for article (PubMed ID: 17201625)
1. Reboxetine use in the treatment of attention-deficit/hyperactivity disorder.
Cak HT; Cetin FC
J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):803-4. PubMed ID: 17201625
[No Abstract] [Full Text] [Related]
2. Treatment of attention-deficit-hyperactivity disorder.
Elia J; Ambrosini PJ; Rapoport JL
N Engl J Med; 1999 Mar; 340(10):780-8. PubMed ID: 10072414
[No Abstract] [Full Text] [Related]
3. Reboxetine for ADHD in children non-responders or with poor tolerance to methylphenidate: a prospective long-term open-label study.
Quintero J; López-Muñoz F; Alamo C; Loro M; García-Campos N
Atten Defic Hyperact Disord; 2010 Nov; 2(3):107-13. PubMed ID: 21432596
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological management of treatment-induced insomnia in ADHD.
Kratochvil CJ; Lake M; Pliszka SR; Walkup JT
J Am Acad Child Adolesc Psychiatry; 2005 May; 44(5):499-501. PubMed ID: 15843773
[No Abstract] [Full Text] [Related]
5. Efficacy of reboxetine in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled clinical trial.
Riahi F; Tehrani-Doost M; Shahrivar Z; Alaghband-Rad J
Hum Psychopharmacol; 2010 Nov; 25(7-8):570-6. PubMed ID: 21312292
[TBL] [Abstract][Full Text] [Related]
6. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
[No Abstract] [Full Text] [Related]
7. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
[TBL] [Abstract][Full Text] [Related]
8. Is the evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder flawed?
Hoekstra PJ; Buitelaar JK
Eur Child Adolesc Psychiatry; 2016 Apr; 25(4):339-40. PubMed ID: 27021055
[No Abstract] [Full Text] [Related]
9. Treatment of attention-deficit/hyperactivity disorder.
Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
[TBL] [Abstract][Full Text] [Related]
10. Tricyclic antidepressants in the treatment of children with attention deficit disorder.
Pliszka SR
J Am Acad Child Adolesc Psychiatry; 1987 Mar; 26(2):127-32. PubMed ID: 3584008
[No Abstract] [Full Text] [Related]
11. Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
Zarinara AR; Mohammadi MR; Hazrati N; Tabrizi M; Rezazadeh SA; Rezaie F; Akhondzadeh S
Hum Psychopharmacol; 2010 Nov; 25(7-8):530-5. PubMed ID: 20860068
[TBL] [Abstract][Full Text] [Related]
12. The use of imipramine in Tourette's syndrome and attention deficit disorder: case report.
Dillon DC; Salzman IJ; Schulsinger DA
J Clin Psychiatry; 1985 Aug; 46(8):348-9. PubMed ID: 2862138
[TBL] [Abstract][Full Text] [Related]
13. Methylphenidate euphoria.
Corrigall R; Ford T
J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1421. PubMed ID: 8936903
[No Abstract] [Full Text] [Related]
14. [Use of drugs in attention deficit hyperactivity disorders].
Guardiola A; Terra AR; Pereira KR; Rotta NT
Arq Neuropsiquiatr; 1997 Sep; 55(3B):594-7. PubMed ID: 9629412
[TBL] [Abstract][Full Text] [Related]
15. Methylphenidate for attention-deficit/hyperactivity disorder: The longest debate.
Levy F
Aust N Z J Psychiatry; 2016 Jul; 50(7):616-7. PubMed ID: 27066820
[No Abstract] [Full Text] [Related]
16. Methylphenidate (Ritalin) use and abuse.
Crutchley A; Temlett JA
S Afr Med J; 1999 Oct; 89(10):1076-9. PubMed ID: 10582063
[No Abstract] [Full Text] [Related]
17. The run on Ritalin. Attention deficit disorder and stimulant treatment in the 1990s.
Diller LH
Hastings Cent Rep; 1996; 26(2):12-8. PubMed ID: 8722521
[No Abstract] [Full Text] [Related]
18. Increase in Menstrual Cycle Length Induced by Extended-Release Methylphenidate in an Adolescent with Attention-Deficit/Hyperactivity Disorder.
Mutlu C; Bahalı K; Gunes H; Adaletli H
J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):860-861. PubMed ID: 26397126
[No Abstract] [Full Text] [Related]
19. Visual fields in children with attention-deficit/hyperactivity disorder before and after treatment with stimulants.
Ghanizadeh A
Acta Ophthalmol; 2010 Mar; 88(2):e56. PubMed ID: 19508459
[No Abstract] [Full Text] [Related]
20. Acute focal dystonic reaction after acute methylphenidate treatment in an adolescent patient.
Tekin U; Soyata AZ; Oflaz S
J Clin Psychopharmacol; 2015 Apr; 35(2):209-11. PubMed ID: 25607477
[No Abstract] [Full Text] [Related]
[Next] [New Search]
